LRR1
Leucine-rich repeat protein 1
Also known as: LLR1_HUMAN, LRR-1, MGC20689, PPIL5
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96L50
- Gene
- LRR1
- Ensembl
- ENSG00000165501
- Chromosome
- 14
- Canonical length
- 414 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear membrane,Vesicles
OverviewNCBI Gene
The protein encoded by this gene contains a leucine-rich repeat (LRR). It specifically interacts with TNFRSF9/4-1BB, a member of the tumor necrosis factor receptor (TNFR) superfamily. Overexpression of this gene suppresses the activation of NF-kappa B induced by TNFRSF9 or TNF receptor-associated factor 2 (TRAF2), which suggests that this protein is a negative regulator of TNFRSF9-mediated signaling cascades. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Feb 2011]
Canonical amino-acid sequenceUniProt
414 residues, UniProt reviewed canonical sequence.
>Q96L50|LRR1
1 MKLHCEVEVI SRHLPALGLR NRGKGVRAVL SLCQQTSRSQ PPVRAFLLIS TLKDKRGTRY
61 ELRENIEQFF TKFVDEGKAT VRLKEPPVDI CLSKAISSSL KGFLSAMRLA HRGCNVDTPV
121 STLTPVKTSE FENFKTKMVI TSKKDYPLSK NFPYSLEHLQ TSYCGLVRVD MRMLCLKSLR
181 KLDLSHNHIK KLPATIGDLI HLQELNLNDN HLESFSVALC HSTLQKSLRS LDLSKNKIKA
241 LPVQFCQLQE LKNLKLDDNE LIQFPCKIGQ LINLRFLSAA RNKLPFLPSE FRNLSLEYLD
301 LFGNTFEQPK VLPVIKLQAP LTLLESSART ILHNRIPYGS HIIPFHLCQD LDTAKICVCG
361 RFCLNSFIQG TTTMNLHSVA HTVVLVDNLG GTEAPIISYF CSLGCYVNSS DMLKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LRR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 27 nTPM
Expression across tissuesHPA
Tissue
- testis: 27 nTPM
- thymus: 22 nTPM
- bone marrow: 21 nTPM
- lymph node: 13 nTPM
- tonsil: 12 nTPM
- colon: 11 nTPM
Single-cell type
- late primary spermatocytes: 346 nCPM
- early spermatids: 104 nCPM
- erythrocyte progenitors: 69 nCPM
- late spermatids: 53 nCPM
- megakaryocytes: 50 nCPM
- monocyte progenitors: 46 nCPM
Immune cell
- eosinophil: 26 nTPM
- intermediate monocyte: 23 nTPM
- basophil: 23 nTPM
- plasmacytoid DC: 18 nTPM
- non-classical monocyte: 17 nTPM
- memory B-cell: 16 nTPM
Brain region
- pons: 1.7 nTPM
- white matter: 1.7 nTPM
- medulla oblongata: 1.6 nTPM
- thalamus: 1.5 nTPM
- cerebellum: 1.4 nTPM
- midbrain: 1.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.44
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.3
- DepMap mean gene effect
- -2.31
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LRR1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LRR1 as an antibody target. Whether an autoantibody or antibody against LRR1 could matter depends on whether native LRR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LRR1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LRR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...